贾 宇,赵兴胜

射血分数保留型心衰（HFpEF）合并高血压构成了心衰患者中一个显著的临床亚型。然而，HFpEF合并高血压的治疗仍然是一个充满挑战的领域，需要更多深入研究来明确最有效的治疗策略为临床医生和研究人员提供更深入的理解和未来研究方向。

高血压；心力衰竭；射血分数保留型心衰

[1] Systematic Review for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention,Detection,Evaluation,and Management of High Blood Pressure in Adults:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. [2] Sciarretta S,Palano F,Tocci G,等.Antihypertensive Treatment and Development of Heart Failure in Hypertension:A Bayesian Network Meta-analysis of Studies in Patients With Hypertension and High Cardiovascular Risk[J]. [3] Mohammed S F,Hussain S,Mirzoyev S A,等.Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction[J]. [4] Lam C S P,Roger V L,Rodeheffer R J,等.Cardiac Structure and Ventricular–Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County,Minnesota[J]. [5] Heidenreich P A,Bozkurt B,Aguilar D,等.2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure:A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. [6] Reddy Y N V,Kaye D M,Handoko M L,等.Diagnosis of Heart Failure With Preserved Ejection Fraction Among Patients With Unexplained Dyspnea[J]. [7] Thibodeau J T,Turer A T,Gualano S K,等.Characterization of a Novel Symptom of Advanced Heart Failure:Bendopnea[J]. [8] Obokata M,Reddy Y N V,Melenovsky V,等.Uncoupling between intravascular and distending pressures leads to underestimation of circulatory congestion in obesity[J]. [9] Iwanaga Y,Nishi I,Furuichi S,等.B-Type Natriuretic Peptide Strongly Reflects Diastolic Wall Stress in Patients With Chronic Heart Failure[J]. [10] Metra M,Adamo M,Gardner R S,等.Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology(ESC)[J]. [11] Reddy Y N V,Carter R E,Obokata M,等.A Simple,Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction[J]. [12] Obokata M,Reddy Y N V,Pislaru S V,等.Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction[J]. [13] Obokata M,Kane G C,Reddy Y N V,等.Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction:A Simultaneous Invasive-Echocardiographic Study[J].Circulation, [14] Jain C C,Borlaug B A.Performance and Interpretation of Invasive Hemodynamic Exercise Testing[J]. [15] Nagueh S F,Smiseth O A,Appleton C P,等.Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography:An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. [16] de Boer E,Petrache I,Mohning M P.Cardiopulmonary Exercise Testing[J]. [17] Reddy Y N V,Olson T P,Obokata M,等.Hemodynamic Correlates and Diagnostic Role of Cardiopulmonary Exercise Testing in Heart Failure With Preserved Ejection Fraction[J]. [18] Kitzman D W,Brubaker P,Morgan T,等.Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction:A Randomized Clinical Trial[J].JAMA,2016,315(1):36. [19] Kitzman D W,Whellan D J,Duncan P,等.Physical Rehabilitation for Older Patients Hospitalized for Heart Failure[J]. [20] Crisci G,De Luca M,D’Assante R,等.Effects of Exercise on Heart Failure with Preserved Ejection Fraction:An Updated Review of Literature[J]. [21] Anker S D,Butler J,Filippatos G,等.Empagliflozin in Heart Failure with a Preserved Ejection Fraction[J]. [22] Solomon S D,McMurray J J V,Claggett B,等.Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction[J]. [23] Abraham W T,Lindenfeld J,Ponikowski P,等.Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction,with and without type 2 diabetes[J]. [24] Nassif M E,Windsor S L,Borlaug B A,等.The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction:a multicenter randomized trial[J]. [25] Zakeri R,Chamberlain A M,Roger V L,等.Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction:A Community-Based Study[J]. [26] January C T,Wann L S,Calkins H,等.2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation:A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons[J]. [27] Pieske B,Wachter R,Shah S J,等.Effect of Sacubitril/Valsartan vs Standard Medical Therapies on Plasma NT-proBNP Concentration and Submaximal Exercise Capacity in Patients With Heart Failure and Preserved Ejection Fraction:The PARALLAX Randomized Clinical Trial[J]. [28] Mancia G,Rosei E A,Azizi M,等.2018 ESC/ESH Guidelines for the management of arterial hypertension[J].

点击下载PDF